Valuation: Caplin Point Laboratories Limited

Capitalization 18TCr 213.63Cr 203.33Cr 188.43Cr 167.6Cr 302.54Cr 335.29Cr 2.35TCr 866.14Cr 7.44TCr 802.01Cr 784.71Cr 32TCr P/E ratio 2025 *
35.7x
P/E ratio 2026 * 31.2x
Enterprise value 18TCr 213.63Cr 203.33Cr 188.43Cr 167.6Cr 302.54Cr 335.29Cr 2.35TCr 866.14Cr 7.44TCr 802.01Cr 784.71Cr 32TCr EV / Sales 2025 *
9.22x
EV / Sales 2026 * 8.1x
Free-Float
25.42%
Yield 2025 *
0.14%
Yield 2026 * 0.15%
More valuation ratios * Estimated data
Dynamic Chart
1 day+3.11%
1 week+4.06%
Current month+11.93%
1 month+22.18%
3 months+25.11%
6 months+68.53%
Current year+81.28%
More quotes
1 week
2 300.40
Extreme 2300.4
2 490.00
1 month
1 914.55
Extreme 1914.55
2 490.00
Current year
1 225.00
Extreme 1225
2 490.00
1 year
1 178.00
Extreme 1178
2 490.00
3 years
575.00
Extreme 575
2 490.00
5 years
176.20
Extreme 176.2
2 490.00
10 years
75.62
Extreme 75.62
2 490.00
More quotes
Director TitleAgeSince
Chief Executive Officer 69 28/03/2015
Director of Finance/CFO - 19/02/2016
Chief Tech/Sci/R&D Officer - 11/06/2024
Manager TitleAgeSince
Chairman 71 27/01/2010
Director/Board Member 69 28/03/2015
Director/Board Member 75 04/03/2020
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+3.05%+4.06% - - 213.63Cr
+0.39%+0.93%+46.36%+138.26%5.12TCr
-0.66%-2.26%+53.47%+112.76%3.12TCr
+0.42%-1.92%+39.52% - 1.88TCr
+0.05%-3.00%+21.08%+63.33%1.38TCr
+1.41%+1.83%+55.95%+112.61%1.16TCr
-.--%+0.14% - - 678.76Cr
-.--%-1.95% - - 572.55Cr
+0.15%-1.26%-33.88%-38.13%531.44Cr
-0.03%-0.23%+4.45%+20.22%523.68Cr
Average +0.48%-1.66%+26.71%+68.17% 1.66TCr
Weighted average by Cap. +0.21%-1.61%+40.58%+107.11%
See all sector performances

Financials

2025 *2026 *
Net sales 1.97TCr 23Cr 22Cr 20Cr 18Cr 33Cr 36Cr 254.51Cr 94Cr 807.46Cr 87Cr 85Cr 3.52TCr 2.24TCr 26Cr 25Cr 23Cr 21Cr 37Cr 41Cr 289.51Cr 106.87Cr 918.5Cr 99Cr 97Cr 4.01TCr
Net income 506.87Cr 5.97Cr 5.68Cr 5.27Cr 4.69Cr 8.46Cr 9.37Cr 66Cr 24Cr 208.13Cr 22Cr 22Cr 908.25Cr 580.63Cr 6.84Cr 6.51Cr 6.04Cr 5.37Cr 9.69Cr 11Cr 75Cr 28Cr 238.42Cr 26Cr 25Cr 1.04TCr
Net Debt - -
More financial data * Estimated data
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,406
More about the company
Date Price Change Volume
11/24/11 2,457.00 +3.05% 204,908
10/24/10 2,384.35 -0.06% 76,389
09/24/09 2,385.90 +1.33% 139,725
06/24/06 2,354.65 -1.09% 201,865
05/24/05 2,380.50 +0.76% 548,056

Delayed Quote NSE India S.E., December 11, 2024 at 02:08 pm IST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
surperformance-ratings-light-chart CAPLIN-POINT-LABORATORIESMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2,385.00INR
Average target price
2,396.67INR
Spread / Average Target
+0.49%
Consensus

Quarterly revenue - Rate of surprise